Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has announced a $6 million expansion of the WA Proteomics Facility, in collaboration with The University of Western Australia, the WA State Government, and Bioplatforms Australia. This investment will enhance the facility’s capabilities in precision diagnostics, enabling industrial-scale screening for medical and agricultural applications. The initiative aims to establish a nationally accredited platform for protein biomarker analysis, which will support the development of diagnostic tests and improve outcomes in clinical and agricultural settings.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, which involves the large-scale study of proteins, aiming to improve disease treatment through innovative diagnostic tools.
Average Trading Volume: 232,061
Technical Sentiment Signal: Sell
Current Market Cap: A$47.42M
See more insights into PIQ stock on TipRanks’ Stock Analysis page.